While the effects of ceramides on AKT signaling are mainly shown in muscle cells and adipocytes, decreasing ceramide synthesis or increasing its degradation in the liver relieves insulin resistance and decreases hepatic steatosis (Chaurasia et al. 2019). This evidence concerns the gene AKT1 and Insulin resistance.